Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Dyslipidemia

  Free Subscription


Articles published in Curr Opin Lipidol

Retrieve available abstracts of 35 articles:
HTML format



Single Articles


    June 2025
  1. PRAKASH Y, Bhatt DL, Malick WA
    Emerging agents targeting triglycerides.
    Curr Opin Lipidol. 2025;36:119-129.
    PubMed     Abstract available


    April 2025
  2. TADA H, Nohara A, Kawashiri MA, Takamura M, et al
    Impact of Achilles tendon on diagnosis and phenotypes of familial hypercholesterolemia.
    Curr Opin Lipidol. 2025 Apr 14. doi: 10.1097/MOL.0000000000000992.
    PubMed     Abstract available


  3. HEGELE RA
    What is the phenotype of heterozygous lipoprotein lipase deficiency?
    Curr Opin Lipidol. 2025;36:96-103.
    PubMed     Abstract available


  4. ISON HE, Helm B, Kringlen G, Crawford P, et al
    Navigating variants of uncertain significance in genetic dyslipidemia: how to assess and counsel patients.
    Curr Opin Lipidol. 2025;36:49-54.
    PubMed     Abstract available


    March 2025
  5. ALNOURI F, Raal FJ
    Familial hypercholesterolemia in pregnancy.
    Curr Opin Lipidol. 2025 Mar 7. doi: 10.1097/MOL.0000000000000980.
    PubMed     Abstract available


    December 2024
  6. TAMEHRI ZADEH SS, Pang J, Chan DC, Watts GF, et al
    A contemporary snapshot of familial hypercholesterolemia registries.
    Curr Opin Lipidol. 2024;35:297-302.
    PubMed     Abstract available


    November 2024
  7. BIRKENHEAD K, Sullivan D, Watts GF, Sarkies MN, et al
    Implementation science and genetic testing for familial hypercholesterolemia.
    Curr Opin Lipidol. 2024 Nov 26. doi: 10.1097/MOL.0000000000000967.
    PubMed     Abstract available


  8. PAQUETTE M, Guay SP, Baass A
    Genetic determinants of pancreatitis risk in hypertriglyceridemia.
    Curr Opin Lipidol. 2024 Nov 11. doi: 10.1097/MOL.0000000000000962.
    PubMed     Abstract available


    September 2024
  9. RAMASWAMI U, Priestley-Barnham L, Humphries SE
    Universal screening for familial hypercholesterolaemia: how can we maximise benefits and minimise potential harm for children and their families.
    Curr Opin Lipidol. 2024 Sep 27. doi: 10.1097/MOL.0000000000000952.
    PubMed     Abstract available


    August 2024
  10. FOSTER C, Gagnon CA, Ashraf AP
    Altered lipid metabolism and the development of metabolic-associated fatty liver disease.
    Curr Opin Lipidol. 2024;35:200-207.
    PubMed     Abstract available


    June 2024
  11. BASHIR B, Ferdousi M, Durrington PN, Soran H, et al
    Pancreatic and cardiometabolic complications of severe hypertriglyceridaemia.
    Curr Opin Lipidol. 2024 Jun 7. doi: 10.1097/MOL.0000000000000939.
    PubMed     Abstract available


  12. MULDER JWCM, Kusters DM, Roeters van Lennep JE, Hutten BA, et al
    Lipid metabolism during pregnancy: consequences for mother and child.
    Curr Opin Lipidol. 2024;35:133-140.
    PubMed     Abstract available


    April 2024
  13. BRUNHAM LR
    Familial hypercholesterolemia-Plus: is the metabolic syndrome changing the clinical picture of familial hypercholesterolemia?
    Curr Opin Lipidol. 2024 Apr 22. doi: 10.1097/MOL.0000000000000938.
    PubMed     Abstract available


  14. CIVEIRA F, Martin C, Cenarro A
    APOE and familial hypercholesterolemia.
    Curr Opin Lipidol. 2024 Apr 17. doi: 10.1097/MOL.0000000000000937.
    PubMed     Abstract available


  15. RASMUSSEN KL, Frikke-Schmidt R
    The current state of apolipoprotein E in dyslipidemia.
    Curr Opin Lipidol. 2024;35:78-84.
    PubMed     Abstract available


  16. WEN Y, Chen YQ, Konrad RJ
    Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism.
    Curr Opin Lipidol. 2024;35:58-65.
    PubMed     Abstract available


    February 2024
  17. CHAN DC, Watts GF
    ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses?
    Curr Opin Lipidol. 2024 Feb 20. doi: 10.1097/MOL.0000000000000920.
    PubMed     Abstract available


  18. VAN DEN BOSCH SE, Hutten BA, Corpeleijn WE, Kusters DM, et al
    Familial hypercholesterolemia in children and the importance of early treatment.
    Curr Opin Lipidol. 2024 Feb 15. doi: 10.1097/MOL.0000000000000926.
    PubMed     Abstract available


  19. PAPONJA K, Pecin I, Reiner Z, Banach M, et al
    Bempedoic acid: new evidence and recommendations on use.
    Curr Opin Lipidol. 2024;35:41-50.
    PubMed     Abstract available


  20. ZHANG Y, de Ferranti SD, Moran AE
    Genetic testing for familial hypercholesterolemia.
    Curr Opin Lipidol. 2024 Feb 1. doi: 10.1097/MOL.0000000000000925.
    PubMed     Abstract available


    December 2023
  21. PERERA SD, Hegele RA
    Genetic variation in apolipoprotein A-V in hypertriglyceridemia.
    Curr Opin Lipidol. 2023 Dec 21. doi: 10.1097/MOL.0000000000000916.
    PubMed     Abstract available


  22. ROMERO-JIMENEZ MJ, Mansilla-Rodriguez ME, Gutierrez-Cortizo EN
    Predictors of cardiovascular risk in familial hypercholesterolemia.
    Curr Opin Lipidol. 2023;34:272-277.
    PubMed     Abstract available


  23. GILLARD BK, Rosales C, Gotto AM Jr, Pownall HJ, et al
    The pathophysiology of excess plasma-free cholesterol.
    Curr Opin Lipidol. 2023;34:278-286.
    PubMed     Abstract available


  24. KARALIS DG
    Strategies of improving adherence to lipid-lowering therapy in patients with atherosclerotic cardiovascular disease.
    Curr Opin Lipidol. 2023;34:252-258.
    PubMed     Abstract available


    November 2023
  25. ROY G, Drouin-Chartier JP
    Cardiovascular disease prevention in heterozygous familial hypercholesterolemia: how important is a healthy diet in the era of long-lasting cholesterol-lowering drug therapies?
    Curr Opin Lipidol. 2023 Nov 2. doi: 10.1097/MOL.0000000000000908.
    PubMed     Abstract available


    October 2023
  26. CHATTOPADHYAY A, Reddy ST, Fogelman AM
    The multiple roles of lysophosphatidic acid in vascular disease and atherosclerosis.
    Curr Opin Lipidol. 2023;34:196-200.
    PubMed     Abstract available


    August 2023
  27. CHOUDHARI P, Patni N
    Updates in the management of pediatric dyslipidemia.
    Curr Opin Lipidol. 2023;34:156-161.
    PubMed     Abstract available


    June 2023
  28. GANDA OP
    Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease.
    Curr Opin Lipidol. 2023;34:105-113.
    PubMed     Abstract available


  29. WADSTROM BN, Pedersen KM, Wulff AB, Nordestgaard BG, et al
    Inflammation compared to low-density lipoprotein cholesterol: two different causes of atherosclerotic cardiovascular disease.
    Curr Opin Lipidol. 2023;34:96-104.
    PubMed     Abstract available


    April 2023
  30. CLARKE SL
    Does low-density lipoprotein fully explain atherosclerotic risk in familial hypercholesterolemia?
    Curr Opin Lipidol. 2023;34:52-58.
    PubMed     Abstract available


  31. HEGELE RA
    DNA testing in dyslipidemia: attitudes and complexities.
    Curr Opin Lipidol. 2023;34:33-34.
    PubMed    


    March 2023
  32. VUORIO A, Raal F, Kovanen PT
    Familial hypercholesterolemia: The nexus of endothelial dysfunction and lipoprotein metabolism in COVID-19.
    Curr Opin Lipidol. 2023 Mar 10. doi: 10.1097/MOL.0000000000000876.
    PubMed     Abstract available


    February 2023
  33. HANG SMT, Hegele RA, Berberich AJ
    Genetic determinants of pancreatitis: relevance in severe hypertriglyceridemia.
    Curr Opin Lipidol. 2023 Feb 2. doi: 10.1097/MOL.0000000000000866.
    PubMed     Abstract available


    January 2023
  34. REIJMAN MD, Defesche JC, Wiegman A
    Genotype-phenotype correlation in a large cohort of pediatric patients with heterozygous and homozygous familial hypercholesterolemia.
    Curr Opin Lipidol. 2023 Jan 18. doi: 10.1097/MOL.0000000000000863.
    PubMed     Abstract available


    December 2022
  35. DRON JS
    The clinical utility of polygenic risk scores for combined hyperlipidemia.
    Curr Opin Lipidol. 2022 Dec 28. doi: 10.1097/MOL.0000000000000865.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.